当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析

华仁药业

(300110)

  

流通市值:37.21亿  总市值:37.24亿
流通股本:11.81亿   总股本:11.82亿

华仁药业(300110)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.17亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益139047.50万元,未分配利润-48397.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产345016.41万元,负债205968.92万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入303,472,326.571,353,161,818.051,073,621,963.53771,461,220.59
营业总成本281,164,064.611,270,221,916.92963,605,145.6683,871,113.39
营业利润17,262,979.02-1,352,991,544.31116,880,614.788,351,006.26
利润总额18,257,296.06-1,355,754,130.81114,410,736.0887,132,398.01
净利润16,546,629.04-1,362,832,173.87100,471,124.1676,714,647.42
其他综合收益----
综合收益总额16,546,629.04-1,362,832,173.87100,471,124.1676,714,647.42
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,169,921,015.631,184,978,609.592,538,801,156.42,629,686,656.68
非流动资产合计2,280,243,118.752,243,141,469.82,333,860,298.842,349,215,960.33
资产总计3,450,164,134.383,428,120,079.394,872,661,455.244,978,902,617.01
流动负债合计1,624,145,658.331,546,631,872.051,424,136,105.821,514,712,134
非流动负债合计435,543,507.66507,559,867.99611,293,712.04650,715,322.37
负债合计2,059,689,165.992,054,191,740.042,035,429,817.862,165,427,456.37
归属于母公司股东权益合计1,316,814,738.651,300,786,289.012,764,796,211.932,742,478,303.3
股东权益合计1,390,474,968.391,373,928,339.352,837,231,637.382,813,475,160.64
负债和股东权益合计3,450,164,134.383,428,120,079.394,872,661,455.244,978,902,617.01
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计351,072,126.071,551,996,783.021,223,799,343.88832,847,736.99
经营活动现金流出小计254,396,574.661,229,636,893.36938,412,528.84671,540,215.31
经营活动产生的现金流量净额96,675,551.41322,359,889.66285,386,815.04161,307,521.68
投资活动现金流入小计-443,614.615,0005,000
投资活动现金流出小计25,822,417.5438,367,476.0337,313,665.5819,696,576.09
投资活动产生的现金流量净额-25,822,417.54-37,923,861.42-37,308,665.58-19,691,576.09
筹资活动现金流入小计232,105,250843,333,192.51649,933,192.51525,860,391.43
筹资活动现金流出小计286,388,113.331,212,835,338.151,010,200,371.64787,631,453.44
筹资活动产生的现金流量净额-54,282,863.33-369,502,145.64-360,267,179.13-261,771,062.01
汇率变动对现金及现金等价物的影响5,076.51556.98246,101.39-3,495.07
现金及现金等价物净增加额16,575,347.05-85,065,560.42-111,942,928.28-120,158,611.49
期末现金及现金等价物余额163,375,100.87146,799,753.82119,922,385.96111,706,702.75
TOP↑